April 06, 2020
Mylan has successfully persuaded the Patent Trial and Appeal Board that one claim of a Sanofi-Aventis patent covering the Lantus SoloStar disposable insulin injection pen is invalid as obvious.
January 15, 2020
The Patent Trial and Appeal Board asked tough questions about the role of injection force during six consolidated inter partes reviews Wednesday in Mylan's effort to knock out several Sanofi-Aventis patents covering the Lantus SoloStar disposable insulin injection pen.